Anxious wait for likely decision on EMA's data access policy
This article was originally published in SRA
Executive Summary
The European Medicines Agency is hoping to get a final decision from its management board on 2 October on its eagerly-awaited policy on proactive publication of clinical trial data. If things go as planned, the policy could come into effect next year with trial data becoming available to the public in 2016.